Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Next-Generation Sequencing-based, Tumor- and Plasma-informed Droplet Digital PCR Assay for Detection of Circulating Tumor DNA in Peripheral T-cell Lymphomas

NCT06362148 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT06362148
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06362148 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Next-Generation Sequencing-based, Tumor- and Plasma-informed Droplet Digital PCR Assay for Detection of Circulating Tumor DNA in Peripheral T-cell Lymphomas
Lead sponsor
University of Aarhus
Phase
Observational
Overall status
Active, not recruiting
Start date
March 1, 2024
Completion date
December 31, 2030
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nk/t-cell lymphoma, peripheral t-cell lymphoma